PDL BioPharma
PDL BioPharma (NASDAQ: PDLI) manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired.
Last updated on
About PDL BioPharma
Estimated Revenue
$100M-$250MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
55Location
City
Incline VillageState
NevadaCountry
United StatesTech Stack (79)
